Protagonist Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:PTGX Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
19 Feb 25	SellUS$204,607	Dinesh Patel	Individual	5,359	US$38.18
26 Nov 24	SellUS$4,600,875	Dinesh Patel	Individual	98,273	US$46.96
15 Nov 24	SellUS$78,108	Arturo Molina	Individual	1,906	US$40.98
11 Sep 24	SellUS$98,232	Asif Ali	Individual	2,203	US$44.59
18 Apr 24	SellUS$30,986	Asif Ali	Individual	1,234	US$25.11

Insider Trading Volume

Insider Buying: PTGX insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of PTGX?
Owner Type	Number of Shares	Ownership Percentage
State or Government	27,076	0.0403%
Individual Insiders	662,403	0.986%
VC/PE Firms	3,250,000	4.84%
Hedge Funds	11,428,551	17%
Institutions	51,816,501	77.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 84.25% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
16.1%	BlackRock, Inc.	9,884,574	US$445.1m	-3.32%	0.01%
9.66%	Farallon Capital Management, L.L.C.	5,930,006	US$267.0m	1.18%	1.34%
8.96%	RTW Investments, LP	5,498,545	US$247.6m	1.33%	3.91%
6.87%	The Vanguard Group, Inc.	4,220,037	US$190.0m	0.09%	no data
5.43%	State Street Global Advisors, Inc.	3,331,061	US$150.0m	4.63%	0.01%
5.29%	Deep Track Capital, LP	3,250,000	US$146.3m	225%	6.2%
3.99%	Johnson & Johnson Innovation - JJDC, Inc.	2,449,183	US$110.3m	0%	37.42%
3.1%	BVF Partners L.P.	1,900,015	US$85.6m	2.69%	3.79%
3.06%	Pacer Advisors, Inc.	1,876,466	US$84.5m	8.21%	0.2%
2.43%	Jefferies Financial Group Inc.,Asset Management Arm	1,489,495	US$67.1m	-17.9%	0.77%
2.27%	T. Rowe Price Group, Inc.	1,392,652	US$62.7m	6.35%	0.01%
2.24%	Geode Capital Management, LLC	1,377,063	US$62.0m	0.17%	no data
2.07%	Perceptive Advisors LLC	1,271,662	US$57.3m	-7.49%	2.01%
1.66%	ADAR1 Capital Management, LLC	1,020,333	US$45.9m	3.98%	9.49%
1.53%	Wellington Management Group LLP	940,077	US$42.3m	3,030%	0.01%
1.51%	American Century Investment Management Inc	928,286	US$41.8m	61.5%	0.02%
1.11%	Eversept Partners, L.P.	678,787	US$30.6m	52.5%	3.51%
1.02%	Northern Trust Global Investments	628,580	US$28.3m	8.36%	no data
0.97%	Goldman Sachs Group, Investment Banking and Securities Investments	595,071	US$26.8m	10.3%	0.01%
0.97%	Invesco Capital Management LLC	593,165	US$26.7m	6.13%	0.01%
0.95%	Woodline Partners LP	582,327	US$26.2m	24.8%	0.2%
0.94%	Charles Schwab Investment Management, Inc.	578,409	US$26.0m	0%	no data
0.72%	FMR LLC	442,343	US$19.9m	-2.58%	no data
0.71%	Morgan Stanley, Investment Banking and Brokerage Investments	434,128	US$19.5m	-16.4%	no data
0.69%	Focus Partners Wealth, LLC	425,557	US$19.2m	-0.26%	0.05%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/04/15 10:05
End of Day Share Price	2025/04/15 00:00
Earnings	2024/12/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Protagonist Therapeutics, Inc. is covered by 21 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Douglas Tsao	Barclays
Mayur Somaiya	BMO Capital Markets Equity Research
Etzer Darout	BMO Capital Markets Equity Research